TOUJEO is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by A-s Medication Solutions. The primary component is Insulin Glargine.
Product ID | 50090-2193_5e6a003a-854a-4097-8994-d35de2f2ec2a |
NDC | 50090-2193 |
Product Type | Human Prescription Drug |
Proprietary Name | TOUJEO |
Generic Name | Insulin Glargine |
Dosage Form | Injection, Solution |
Route of Administration | SUBCUTANEOUS |
Marketing Start Date | 2015-02-25 |
Marketing Category | NDA / NDA |
Application Number | NDA206538 |
Labeler Name | A-S Medication Solutions |
Substance Name | INSULIN GLARGINE |
Active Ingredient Strength | 300 U/mL |
Pharm Classes | Insulin [Chemical/Ingredient],Insulin Analog [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2019-12-31 |
Marketing Start Date | 2015-10-26 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA206538 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2015-10-26 |
Marketing End Date | 2019-01-31 |
Ingredient | Strength |
---|---|
INSULIN GLARGINE | 300 U/mL |
SPL SET ID: | 257ca17b-6ff7-4f2e-9037-4c185bac5768 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
PHarm Class EPC | |
NUI Code |
NDC | Brand Name | Generic Name |
---|---|---|
0024-5869 | TOUJEO | insulin glargine |
50090-2193 | TOUJEO | TOUJEO |
0002-7715 | BASAGLAR | Insulin glargine |
0002-8214 | BASAGLAR | Insulin glargine |
0088-2220 | Lantus | insulin glargine |
0088-2219 | Lantus Solostar | insulin glargine |
0024-5871 | TOUJEO Max | insulin glargine |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
TOUJEO 86327965 4939032 Live/Registered |
Sanofi 2014-07-03 |
TOUJEO 85835283 4469082 Live/Registered |
Sanofi 2013-01-29 |